The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Evonik invests in start-up to improve patient recovery after open-chest surgery
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
The new centre will comprise a team of 50 highly experienced specialists
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
Subscribe To Our Newsletter & Stay Updated
